| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ramaswamy Vivek | 10%+ Owner | C/O STEVE ROBERTS, 853 NEW JERSEY AVE., SUITE 200-231, WASHINGTON | Stephen Roberts, as Attorney-in-Fact for Vivek Ramaswamy | 06 Jun 2025 | 0001635075 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ROIV | Common Shares | Sale | $6,207,856 | -547,430 | -1.4% | $11.34 | 38,627,181 | 04 Jun 2025 | Direct | F1 |
| transaction | ROIV | Common Shares | Sale | $2,246,952 | -200,800 | -0.52% | $11.19 | 38,426,381 | 06 Jun 2025 | Direct | F2 |
| holding | ROIV | Common Shares | 13,357,857 | 04 Jun 2025 | Spousal | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.47, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4 |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.31, inclusive. |
| F3 | Represents the quantity of shares held indirectly only |